Cooley advised China International Capital Corporation Hong Kong Securities Limited (CICC) and other underwriters on Laekna’s HK$791 million (US$101 million) initial public offering of 63,728,000 shares on the Hong Kong Stock Exchange, the largest 18A offering year to date. Founded in 2016, Laekna is a science-driven, clinical-stage biotechnology company. Partners Michael Yu and Yiming Liu led the Cooley team.